Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members

Molecular and Cellular Biology
Qiong JiangScott K Durum

Abstract

The antiapoptotic function of the interleukin-7 (IL-7) receptor is related to regulation of three members of the Bcl2 family: synthesis of Bcl2, phosphorylation of Bad, and cytosolic retention of Bax. Here we show that, in an IL-7-dependent murine T-cell line, different regions of the IL-7 receptor initiate the signal transduction pathways that regulate these proteins. Both Box1 and Y449 are required to signal Bcl2 synthesis and Bax cytosolic retention. This suggests a sequential model in which Jak1, which binds to Box1, is first activated and then phosphorylates Y449, leading to Bcl2 and Bax regulation, accounting for approximately 90% of the survival function. Phosphorylation of Bad required Box1 but not Y449, suggesting that Jak1 also initiates an additional signaling cascade that accounts for approximately 10% of the survival function. Stat5 was activated from the Y449 site but only partially accounted for the survival signal. Proliferation required both Y449 and Box1. Thymocyte development in vivo showed that deletion of Y449 eliminated 90% of alphabeta T-cell development and completely eliminated gammadelta T-cell development, whereas deleting Box 1 completely eliminated both alphabeta and gammadelta T-cell development. T...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A R Venkitaraman, R J Cowling
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M MurakamiT Kishimoto
Nov 3, 1995·Science·T NosakaJ N Ihle
Nov 1, 1995·European Journal of Immunology·B M FoxwellD Cantrell
Apr 1, 1995·The Journal of Experimental Medicine·S K BhatiaT J Waldschmidt
Apr 1, 1995·The Journal of Experimental Medicine·U von Freeden-JeffryR Murray
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·J P DiSantoK Rajewsky
Nov 1, 1994·The Journal of Experimental Medicine·J J PeschonB L Davison
Jul 1, 1993·The Journal of Experimental Medicine·K H GrabsteinP J Morrissey
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·K MakiK Ikuta
Aug 1, 1996·Human Gene Therapy·T M Kinsella, G P Nolan
Nov 20, 1998·Current Opinion in Biotechnology·G P Nolan, A R Shatzman
Nov 27, 1999·The Journal of Biological Chemistry·Y TanM J Comb
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·A R KhaledS K Durum
Mar 4, 2000·The Journal of Biological Chemistry·N BenbernouS K Durum
Mar 23, 2001·Nature Immunology·K S SchlunsL Lefrançois
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B O PorterT R Malek
Nov 16, 2002·Immunity·Annette R KhaledScott K Durum
Mar 1, 2003·Journal of Immunological Methods·Kyungjae KimScott K Durum

❮ Previous
Next ❯

Citations

May 1, 2008·Cellular & Molecular Immunology·Megan J PalmerJianzhu Chen
Jan 30, 2007·Nature Reviews. Immunology·Renata Mazzucchelli, Scott K Durum
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yrina RochmanWarren J Leonard
Jan 23, 2009·Animal Biotechnology·Yu Jin HurYoung Bong Kim
Feb 28, 2007·The Journal of Experimental Medicine·Lisa C OsborneNinan Abraham
Oct 25, 2007·International Immunology·Agatha VranjkovicJonathan B Angel
Mar 6, 2010·International Immunology·T Kent TeagueC Justin Van De Wiele
Nov 26, 2009·Molecular and Cellular Biology·Wen Qing LiScott K Durum
Jul 21, 2007·BMC Evolutionary Biology·Clifford Liongue, Alister C Ward
Sep 17, 2011·Retrovirology·Charlene D Young, Jonathan B Angel
May 16, 2012·PloS One·Federico SimonettaChristine Bourgeois
Apr 30, 2013·Cellular and Molecular Life Sciences : CMLS·Noa TalShai Izraeli
Jan 30, 2010·Human Genetics·Rebecca L ZuvichJonathan L Haines
May 1, 2013·Molecular Immunology·Michelle R HunterMichael C Jensen
Apr 16, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ann M LeenJuan F Vera
Jul 16, 2005·Leukemia & Lymphoma·Joao T BarataVassiliki A Boussiotis
Sep 17, 2011·Seminars in Immunology·Tarik Möröy, Cyrus Khandanpour
Aug 3, 2011·Cytokine·Shoshana D KatzmanAbul K Abbas
Jan 16, 2010·Human Immunology·Julie H MarinoT Kent Teague
Jan 6, 2006·The EMBO Journal·Heming ZhuKathrin Muegge
Jul 20, 2010·Immunological Reviews·Ryan D Michalek, Jeffrey C Rathmell
Oct 31, 2009·European Journal of Immunology·Victoria J LawsonDiane Maurice
Nov 24, 2005·Seminars in Immunology·Craig D Milne, Christopher J Paige
Jul 6, 2005·Cytokine & Growth Factor Reviews·Qiong JiangScott K Durum
Jul 1, 2015·Experimental Hematology·Kaat DurinckPieter Van Vlierberghe
Sep 5, 2007·Cytokine·Christina Kittipatarin, Annette R Khaled
Dec 23, 2008·Immunity·Charles D Surh, Jonathan Sprent
Mar 8, 2011·The Journal of Allergy and Clinical Immunology·Mübeccel AkdisCezmi A Akdis
May 16, 2009·Developmental and Comparative Immunology·Daphne A van HaarlemLonneke Vervelde

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

Immunological Reviews
Annette R Khaled, Scott K Durum
Proceedings of the National Academy of Sciences of the United States of America
Joyce T TanCharles D Surh
The Journal of Cell Biology
Annette R KhaledScott K Durum
The Journal of Experimental Medicine
Wen Qing LiScott K Durum
© 2022 Meta ULC. All rights reserved